编辑文章 - 后台系统

编辑文章

编辑文章

文章标题：

关键字：

所属疾病：

所属类别：

标　　签：

文章主图*

点击“Select image”更换图片

Select image Change Remove

注意! 最佳图片尺寸800*800

内容详情：

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><strong><a href="http://www.india-drugstore.com/p/drug_detail.php?navid=6&id=11"><span style="color:#3498db;"><span class="15" style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">瑞戈非尼</font></span></span></span></span></span></span></span></a></strong><a href="http://www.india-drugstore.com/p/drug_detail.php?navid=6&id=11"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#3498db;"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑"><strong>(瑞格非尼)</strong></font></span></span></span></span></span></span></span></a><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">是一种激酶抑制剂，瑞格非尼适用于不能通过手术切除以及使用其它已上市药物治疗无效的晚期胃肠道间质瘤(GIST)患者治疗。瑞格非尼规格：瑞格非尼40mg，瑞格非尼28片/盒。</font></span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.2000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">   </font></span></span></span></span></span></span></span></span></span></p>

<p style="margin:0pt 0pt 0.0001pt; text-align:justify"><span style="font-size:10.5pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.2000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">在2017年3月24日 ，瑞戈非尼经国家食品药品监督管理总局（CFDA）批准，分别用于治疗既往接受过以氟尿嘧啶、奥沙利铂和伊立替康为基础的化疗，以及既往接受过或不适合接受抗VEGF治疗、抗EGFR治疗（RAS野生型）的转移性结直肠癌（mCRC）患者。</font></span></span></span></span></span></span></span></span></span></p>

<p class="p" style="margin-top:0.0000pt; margin-right:0.0000pt; margin-bottom:3.7500pt; margin-left:0.0000pt; padding:0pt 0pt 0pt 0pt ; margin:5pt 0pt; text-align:left"> </p>

<p class="p" style="margin-top:0.0000pt; margin-right:0.0000pt; margin-bottom:3.7500pt; margin-left:0.0000pt; padding:0pt 0pt 0pt 0pt ; margin:5pt 0pt; text-align:left"><span style="font-size:12pt"><span style="background:#ffffff"><span style="line-height:18.4000pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">(1)瑞格非尼推荐剂量：瑞格非尼160mg口服。瑞格非尼每天1次每28天疗程的头21天。</font></span></span></span></span></span></span></span></span></span></span></span></p>

<p class="p" style="margin-top:0.0000pt; margin-right:0.0000pt; margin-bottom:3.7500pt; margin-left:0.0000pt; padding:0pt 0pt 0pt 0pt ; margin:5pt 0pt; text-align:left"><span style="font-size:12pt"><span style="background:#ffffff"><span style="line-height:18.4000pt"><span style="font-family:Calibri"><span style="font-size:12.0000pt"><span style="background:#ffffff"><span style="font-family:微软雅黑"><span style="color:#000000"><span style="letter-spacing:0.0000pt"><span style="text-transform:none"><span style="font-style:normal"><font face="微软雅黑">(2)瑞格非尼与食物服用Stivarga(一种低脂肪早餐)。瑞格非尼不良反应：瑞格非尼最常见不良反应(≥30%)是乏力/疲乏、减低食欲和食物摄入量、手足皮肤反应(HFSR)、腹泻、口腔粘膜炎、体重减轻、感染、高血压和发音困难。</font></span></span></span></span></span></span></span></span></span></span></span></p>

首页显示：

显示不显示

热门文章：

是否

阅读：